Apr 3, 2014

Heads roll at Novartis over scandal

Swiss pharmaceutical giant Novartis said Thursday it is replacing the top executives at its Japanese unit over allegations that the division hid the existence of serious potential side effects linked to leukemia treatments from regulators. David Epstein, head of the firm’s pharmaceutical division, told ...

May 8, 2013

Lessons from the Iressa case

The Supreme Court upholds rulings that the Japanese unit of British drug maker AstraZeneca PLC is not liable for fatal side effects of the lung cancer drug Iressa.